Saudi Arabia's 3D imaging market is projected to grow from $0.52 Bn in 2022 to $1.94 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. The market will be driven by increasing awareness of the advantages of 3D Imaging and government initiatives such as collaborations and privatization. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.
Saudi Arabia's 3D imaging market is projected to grow from $0.52 Bn in 2022 to $1.94 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. In recent years, the Saudi government has taken a number of steps to improve healthcare in the Country, including increasing the healthcare budget and promoting private-sector engagement in healthcare. Additionally, Saudi Arabia is focusing on ways to reduce healthcare expenses, such as expanding access to treatment through digital health technologies, increasing the use of preventative care, and supporting healthy lifestyle choices. It will spend $36.8 Bn on healthcare and social development in 2022, accounting for 14.4 % of its budget. Cardiovascular diseases (CVD) are the major cause of death in Saudi Arabia, accounting for 45.7% of all fatalities. Also, the Age-standardized incidence rate (ASIR) for all forms of cancer is 88.7 per 100,000 people, whereas the age-standardized mortality rate (ASMR) is 43.3 per 100,000 people.
In Saudi Arabia, 3D Imaging technology has been in use for various applications such as Diagnostic imaging, Surgical planning, Dentistry, Orthopaedics & Research. In February 2023, At Arab Health 2023 in Dubai, China-based business United Imaging announced a collaboration and research arrangement with Saudi Arabia's I-ONE Nuclear Medicine & Cancer Institute for the first PET/MR uPMR 790 in the Gulf nations. Total imaging volumes in the Aseer Area of Saudi Arabia in 2021 were 159,107 in 2020, representing a 22.7% decrease from the previous year owing to the pandemic but as the services resumed the volumes were recovering back to normal.
Market Growth Drivers
To promote 3D Imaging technology, the Saudi government has formed partnerships and cooperation with foreign organizations and universities. The King Abdullah University of Science and Technology (KAUST), for example, has collaborated with the University of California, San Francisco (UCSF) to develop improved imaging technology for early cancer diagnosis. The Saudi government has also made significant investments in the healthcare industry, including the creation of new hospitals and medical facilities, as well as the application of innovative medical technology such as 3D medical imaging. Patients in Saudi Arabia are becoming increasingly aware of the advantages of 3D medical imaging, such as the capacity to diagnose illnesses earlier and the possibility of less intrusive treatments. As a result, demand for these services is expected to rise in the coming years. Moreover, other factors such as the introduction of new imaging modalities with improved accuracy and reliability of medical imaging, rising demand for personalized medicine, and the increasing prevalence of chronic diseases such as cancer, heart disease, and diabetes are all factors driving the growth of 3D Imaging in Saudi Arabia.
Market Restraints
Limited availability in some areas, high cost, a lack of qualified healthcare professionals, cultural and social barriers, and regulatory issues are among the challenges and setbacks to the growth of 3D Imaging in Saudi Arabia. Resolving these obstacles would need continuing investment, training, and collaboration to assure the country's continued growth and acceptance of 3D medical imaging.
Key Players
The Saudi Food and Drug Administration (SFDA) oversees and regulates the import and distribution of medical equipment, medicines, and food items in Saudi Arabia. In the case of medical devices, the SFDA will typically accept, register, and authorize the marketing and sale of any device that conforms with relevant provisions of the SFDA's Interim Regulations and relevant regulatory requirements applicable in one or more of the Global Harmonization Task Force member countries (GHTF).
The Ministry of Health (MOH) is the primary government institution in charge of providing preventative, curative, and rehabilitative healthcare to the Kingdom's people. The Ministry of Health offers primary healthcare (PHC) services throughout the Kingdom through a network of healthcare institutions. The Ministry of Health intends to privatize all of its services under the National Transformation Program 2020, which would raise the private sector's involvement in the health sector from 25-35% and convert government hospitals into semi-public corporations. By 2020, around 20 million Saudi people will require insurance coverage as a result of this privatization program.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product (Revenue, USD Billion):
The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.
By Application (Revenue, USD Billion):
The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.
By End User (Revenue, USD Billion):
Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.
By Portability (Revenue, USD Billion):
The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.